99 related articles for article (PubMed ID: 7809021)
21. Effects of cyclosporin A and alpha-difluoromethylornithine on the growth of hamster pancreatic cancer in vitro.
Saydjari R; Townsend CM; Barranco SC; James E; Thompson JC
J Natl Cancer Inst; 1986 Nov; 77(5):1087-92. PubMed ID: 3022056
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of bombesin on growth of gastrinoma (PT) in vivo.
Chu KU; Ishizuka J; Battey JF; Uchida T; Beauchamp RD; Townsend CM; Thompson JC
Dig Dis Sci; 1996 Nov; 41(11):2180-6. PubMed ID: 8943970
[TBL] [Abstract][Full Text] [Related]
23. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
Narayan S; Guo YS; Townsend CM; Singh P
Cancer Res; 1990 Nov; 50(21):6772-8. PubMed ID: 2208141
[TBL] [Abstract][Full Text] [Related]
24. Effects of bombesin on growth of human small cell lung carcinoma in vivo.
Alexander RW; Upp JR; Poston GJ; Gupta V; Townsend CM; Thompson JC
Cancer Res; 1988 Mar; 48(6):1439-41. PubMed ID: 2830965
[TBL] [Abstract][Full Text] [Related]
25. Effects of bombesin on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
Cancer Lett; 1991 Jul; 59(1):45-50. PubMed ID: 1878860
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of gut hormones on pancreatic and intestinal growth during administration of an elemental diet.
Evers BM; Izukura M; Townsend CM; Uchida T; Thompson JC
Ann Surg; 1990 May; 211(5):630-6; discussion 636-8. PubMed ID: 2339923
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
Pinski J; Halmos G; Yano T; Szepeshazi K; Qin Y; Ertl T; Schally AV
Int J Cancer; 1994 May; 57(4):574-80. PubMed ID: 7910153
[TBL] [Abstract][Full Text] [Related]
28. Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptors status.
Bold RJ; Ishizuka J; Yao CZ; Townsend CM; Thompson JC
Anticancer Res; 1998; 18(6A):4051-6. PubMed ID: 9891444
[TBL] [Abstract][Full Text] [Related]
29. Effects of pancreastatin (24-49) on growth of normal pancreas and pancreatic cancer.
Smith JP; Kramer S; Bagheri S
Pancreas; 1991 Sep; 6(5):551-7. PubMed ID: 1946312
[TBL] [Abstract][Full Text] [Related]
30. Treatment of hamster pancreatic cancer with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis.
Marx M; Townsend CM; Barranco SC; Glass EJ; Thompson JC
J Natl Cancer Inst; 1987 Sep; 79(3):543-8. PubMed ID: 3114535
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice.
Radulovic S; Schally AV; Reile H; Halmos G; Szepeshazi K; Groot K; Milovanovic S; Miller G; Yano T
Acta Oncol; 1994; 33(6):693-701. PubMed ID: 7946450
[TBL] [Abstract][Full Text] [Related]
32. Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP.
Qin Y; Ertl T; Cai RZ; Horvàth JE; Groot K; Schally AV
Int J Cancer; 1995 Oct; 63(2):257-62. PubMed ID: 7591214
[TBL] [Abstract][Full Text] [Related]
33. New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors.
García Garayoa E; Schweinsberg C; Maes V; Rüegg D; Blanc A; Bläuenstein P; Tourwé DA; Beck-Sickinger AG; Schubiger PA
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):42-50. PubMed ID: 17372572
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor alpha is trophic to pancreatic cancer in vivo.
Davies N; Kapur P; Gillespie J; Guillou PJ; Poston GJ
Gut; 1993 Aug; 34(8):1097-8. PubMed ID: 8174961
[TBL] [Abstract][Full Text] [Related]
35. Bombesin-like peptides: candidates as diagnostic and therapeutic tools.
Yeğen BC
Curr Pharm Des; 2003; 9(12):1013-22. PubMed ID: 12678868
[TBL] [Abstract][Full Text] [Related]
36. Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth.
Evers BM; Townsend CM; Upp JR; Allen E; Hurlbut SC; Kim SW; Rajaraman S; Singh P; Reubi JC; Thompson JC
Gastroenterology; 1991 Aug; 101(2):303-11. PubMed ID: 1712329
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic regeneration after subtotal distal resection in rats. Effects of bombesin and octreotide by the in vivo bromodeoxyuridine uptake technique.
Bufalari A; Ferri M; Sidoni A; Alberti P; Giustozzi G; Moggi L
Eur Surg Res; 1999; 31(5):412-8. PubMed ID: 10529555
[TBL] [Abstract][Full Text] [Related]
38. Bombesin stimulates intracellular Ca2+ mobilization but not proliferation on human colon cancer cells.
Hirai M; Ishizuka J; Hirai A; Bold RJ; Townsend CM; Thompson JC
Life Sci; 1993; 53(24):1859-65. PubMed ID: 8246684
[TBL] [Abstract][Full Text] [Related]
39. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
40. Effect of human growth hormone on human pancreatic carcinoma growth, protein, and cell cycle kinetics.
Harrison LE; Blumberg D; Berman R; Ng B; Hochwald S; Brennan MF; Burt M
J Surg Res; 1996 Mar; 61(2):317-22. PubMed ID: 8656602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
